In lung cancer, Nestin was reportedly capable of protecting Nrf2 from kelch-like ECH-associated protein 1 (Keap1)-modulated degradation and was able to increase the expression levels of antioxidant enzymes. This evidence concerns the gene NFE2L2 and lung cancer.